Who Supplies Ketorolac? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Ketorolac exports, with 351+ registered manufacturers shipping to buyers across 124+ countries — yet a handful of companies dominate the shipments. GLAND PHARMA LTD holds the largest share at 13.6% (export value: $15.7M). Close behind, GLAND PHARMA LIMITED (11.0%, $12.7M). ALEMBIC PHARMACEUTICALS LIMITED (10.3%, $12.0M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Ketorolac? Top Manufacturers & Their Buyers
Flow of Ketorolac from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Ketorolac Supplier Network — Key Market Intelligence
The Ketorolac export market from India is led by GLAND PHARMA LTD, which alone commands a 13.6% share, shipping $15.7M worth of product across 193 shipments. The second-largest exporter, GLAND PHARMA LIMITED, contributes $12.7M (11.0%) to the overall market. Combined, the top two suppliers alone account for 24.5% of all Ketorolac exports, indicating a relatively concentrated supply base.
Across all 351 tracked manufacturers, the total Ketorolac export value stands at $115.9M from 3.0K shipments. The market average shipment value is $39.1K. The single largest buyer relationship in terms of trade value is EVERSANA LIFE SCIENCE SERVICES LLC, receiving $13.4M worth of product.
The combined buyer network spans 18 named purchasing companies, including EVERSANA LIFE SCIENCE SERVICES LLC, JUNO PHARMACEUTICALS CORP, BOSTON ONCOLOGY ARAB, EVERSANA EVERSANA, EVERSANA and 13 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1GLAND PHARMA LTD
GLAND PHARMA LTD is the first-largest Ketorolac exporter from India, with a market share of 13.6% and a total export value of $15.7M across 193 shipments. Their average shipment value of $81.4K is above the market average of $39.1K, suggesting premium or bulk contract pricing.
GLAND PHARMA LTD serves 5 named buyers in our database. EVERSANA LIFE SCIENCE SERVICES LLC is the dominant customer, accounting for 85.3% of this supplier's tracked business. Top customers include:
• EVERSANA LIFE SCIENCE SERVICES LLC — $13.4M across 165 shipments (85.3% of this supplier's total exports)
• JUNO PHARMACEUTICALS CORP — $874.4K across 11 shipments (5.6% of this supplier's total exports)
• BOSTON ONCOLOGY ARAB — $549.8K across 7 shipments (3.5% of this supplier's total exports)
• JUNO PHARMACEUTICALS CORP — $453.7K across 6 shipments (2.9% of this supplier's total exports)
• EVERSANA LIFE SCIENCE SERVICES LLC — $424.4K across 5 shipments (2.7% of this supplier's total exports)
Key Insight: GLAND PHARMA LTD's per-shipment value of $81.4K is 108% above the market average of $39.1K, consistent with large-order contracts or value-added formulations.
2GLAND PHARMA LIMITED
GLAND PHARMA LIMITED is the second-largest Ketorolac exporter from India, with a market share of 11.0% and a total export value of $12.7M across 212 shipments. Their average shipment value of $59.9K is above the market average of $39.1K, suggesting premium or bulk contract pricing.
GLAND PHARMA LIMITED serves 5 named buyers in our database. EVERSANA LIFE SCIENCE SERVICES LLC is the dominant customer, accounting for 64.3% of this supplier's tracked business. Top customers include:
• EVERSANA LIFE SCIENCE SERVICES LLC — $8.2M across 136 shipments (64.3% of this supplier's total exports)
• EVERSANA EVERSANA — $2.6M across 43 shipments (20.4% of this supplier's total exports)
• EVERSANA — $783.0K across 13 shipments (6.2% of this supplier's total exports)
• JUNO PHARMACEUTICALS CORP — $780.8K across 13 shipments (6.2% of this supplier's total exports)
• ALMAJECT — $382.5K across 6 shipments (3.0% of this supplier's total exports)
Key Insight: GLAND PHARMA LIMITED's per-shipment value of $59.9K is 53% above the market average of $39.1K, consistent with large-order contracts or value-added formulations.
3ALEMBIC PHARMACEUTICALS LIMITED
ALEMBIC PHARMACEUTICALS LIMITED is the third-largest Ketorolac exporter from India, with a market share of 10.3% and a total export value of $12.0M across 70 shipments. Their average shipment value of $170.9K is above the market average of $39.1K, suggesting premium or bulk contract pricing.
ALEMBIC PHARMACEUTICALS LIMITED serves 4 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• J KNIPPER COMPANY — $5.3M across 31 shipments (44.7% of this supplier's total exports)
• J KNIPPER COMPANY — $3.1M across 18 shipments (26.2% of this supplier's total exports)
• J KNIPPER COMPANY — $2.6M across 15 shipments (22.0% of this supplier's total exports)
• J. KNIPPER & COMPANY. — $853.5K across 5 shipments (7.1% of this supplier's total exports)
Key Insight: ALEMBIC PHARMACEUTICALS LIMITED's per-shipment value of $170.9K is 337% above the market average of $39.1K, consistent with large-order contracts or value-added formulations.
4CAPLIN STERILES LIMITED
CAPLIN STERILES LIMITED is the fourth-largest Ketorolac exporter from India, with a market share of 7.8% and a total export value of $9.1M across 230 shipments. Their average shipment value of $39.5K is above the market average of $39.1K, suggesting premium or bulk contract pricing.
CAPLIN STERILES LIMITED serves 5 named buyers in our database. BAXTER HEALTHCARE CORPORATION is the dominant customer, accounting for 55.2% of this supplier's tracked business. Top customers include:
• BAXTER HEALTHCARE CORPORATION — $5.0M across 127 shipments (55.2% of this supplier's total exports)
• NORTHSTAR DISTRIBUTION CENTER — $2.1M across 53 shipments (22.9% of this supplier's total exports)
• SOLA PHARMACEUTICALS — $1.2M across 31 shipments (13.3% of this supplier's total exports)
• GLEANMARK PHARMCEUTI — $415.2K across 11 shipments (4.6% of this supplier's total exports)
• GLENMARK PHARMACEUTI — $364.6K across 9 shipments (4.0% of this supplier's total exports)
Key Insight: CAPLIN STERILES LIMITED's per-shipment value of $39.5K is 1% above the market average of $39.1K, consistent with large-order contracts or value-added formulations.
5SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fifth-largest Ketorolac exporter from India, with a market share of 7.7% and a total export value of $8.9M across 95 shipments. Their average shipment value of $94.0K is above the market average of $39.1K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 3 named buyers in our database. AO RANBAXY is the dominant customer, accounting for 70.3% of this supplier's tracked business. Top customers include:
• AO RANBAXY — $6.3M across 67 shipments (70.3% of this supplier's total exports)
• AO RANBAXY — $2.7M across 28 shipments (29.7% of this supplier's total exports)
• REPRESENTATIVE OFFIC — $24 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $94.0K is 140% above the market average of $39.1K, consistent with large-order contracts or value-added formulations.
6MICRO LABS LIMITED
MICRO LABS LIMITED is the fifth-largest Ketorolac exporter from India, with a market share of 3.0% and a total export value of $3.5M across 60 shipments. Their average shipment value of $58.0K is above the market average of $39.1K, suggesting premium or bulk contract pricing.
MICRO LABS LIMITED serves 5 named buyers in our database. EVERSANA LIFE SCIENCE SERVICES LLC is the dominant customer, accounting for 69.9% of this supplier's tracked business. Top customers include:
• EVERSANA LIFE SCIENCE SERVICES LLC — $2.4M across 42 shipments (69.9% of this supplier's total exports)
• EVERSANA LIFE SCIENCE SERVICES LLC — $653.5K across 11 shipments (18.8% of this supplier's total exports)
• MICRO LABS GMBH — $181.4K across 3 shipments (5.2% of this supplier's total exports)
• MSK PHARMALOGISTIC G — $135.6K across 2 shipments (3.9% of this supplier's total exports)
• BROWN AND BURK UK LI — $75.8K across 1 shipments (2.2% of this supplier's total exports)
Key Insight: MICRO LABS LIMITED's per-shipment value of $58.0K is 48% above the market average of $39.1K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Ketorolac Flows
Once Ketorolac leaves the manufacturing plants of companies like GLAND PHARMA LTD and GLAND PHARMA LIMITED, it travels to 5 destination markets with a combined import value of $115.9M. United States absorbs the largest share at 63.1% ($73.2M), followed by Russia (23.4%) and Canada (2.7%).
In United States — the top destination — named importers include EVERSANA LIFE SCIENCE SERVICES, BAXTER HEALTHCARE CORPORATION, J KNIPPER COMPANY. In Russia, key buyers are AO "RANBAXY", AO RANBAXY.
This geographic spread reflects Ketorolac's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Ketorolac Go? Top Importing Countries & Their Buyers
Trade flow of Ketorolac exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Ketorolac imports from India, with a total trade value of $73.2M across 613 shipments — representing a 63.1% share of all Ketorolac exports. The average shipment value of $119.3K is above the global average of $39.1K, indicating high-value procurement contracts or branded formulations. This market is served by 15 tracked buyers.
Named Ketorolac importers in United States: EVERSANA LIFE SCIENCE SERVICES is the largest buyer, accounting for 35.5% ($26.0M) of this market's total imports.
• EVERSANA LIFE SCIENCE SERVICES — $26.0M (35.5% of United States's total)
• BAXTER HEALTHCARE CORPORATION — $6.6M (9.0% of United States's total)
• J KNIPPER COMPANY — $5.5M (7.6% of United States's total)
Key Insight: United States's per-shipment average of $119.3K (205% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Ketorolac imports from India.
2Russia
Russia ranks as the second-largest destination for Ketorolac imports from India, with a total trade value of $27.1M across 90 shipments — representing a 23.4% share of all Ketorolac exports. The average shipment value of $301.1K is above the global average of $39.1K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Ketorolac importers in Russia: AO "RANBAXY" is the largest buyer, accounting for 67.4% ($18.3M) of this market's total imports.
• AO "RANBAXY" — $18.3M (67.4% of Russia's total)
• AO RANBAXY — $6.7M (24.7% of Russia's total)
Key Insight: Russia's per-shipment average of $301.1K (670% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Russia is a key market for Ketorolac imports from India.
3Canada
Canada ranks as the third-largest destination for Ketorolac imports from India, with a total trade value of $3.1M across 36 shipments — representing a 2.7% share of all Ketorolac exports. The average shipment value of $86.9K is above the global average of $39.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Ketorolac importers in Canada: JUNO PHARMACEUTICALS CORP is the largest buyer, accounting for 54.4% ($1.7M) of this market's total imports.
• JUNO PHARMACEUTICALS CORP — $1.7M (54.4% of Canada's total)
Key Insight: Canada's per-shipment average of $86.9K (122% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Ketorolac imports from India.
4Ecuador
Ecuador ranks as the fourth-largest destination for Ketorolac imports from India, with a total trade value of $2.3M across 32 shipments — representing a 2.0% share of all Ketorolac exports. The average shipment value of $71.0K is above the global average of $39.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Ketorolac importers in Ecuador: DYVENPRO DISTRIBUCION Y VENTA DE is the largest buyer, accounting for 48.7% ($1.1M) of this market's total imports.
• DYVENPRO DISTRIBUCION Y VENTA DE — $1.1M (48.7% of Ecuador's total)
Key Insight: Ecuador's per-shipment average of $71.0K (81% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Ecuador is a key market for Ketorolac imports from India.
5United Arab Emirates
United Arab Emirates ranks as the fifth-largest destination for Ketorolac imports from India, with a total trade value of $1.0M across 0 shipments — representing a 0.9% share of all Ketorolac exports. The average shipment value of $1.0M is above the global average of $39.1K, indicating high-value procurement contracts or branded formulations.
Key Insight: United Arab Emirates's per-shipment average of $1.0M (2547% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Arab Emirates is a key market for Ketorolac imports from India.
People Also Ask — Ketorolac Supplier & Trade Network
Who are the top suppliers of Ketorolac from India?+
Which companies buy Ketorolac from Indian manufacturers?+
Where does Ketorolac exported from India go?+
What is the market share of the top Ketorolac supplier from India?+
What is the average shipment value for Ketorolac exports from India?+
Is Ketorolac manufactured in India and exported globally?+
Which country imports the most Ketorolac from India?+
Who are the buyers of Ketorolac in Russia?+
How concentrated is the Ketorolac supplier market in India?+
How do I find verified buyers for Ketorolac in specific countries?+
Ketorolac Trade Network — Key Takeaways
- 1GLAND PHARMA LTD is India's dominant Ketorolac exporter with a 13.6% market share and $15.7M in total exports — making it the single most important sourcing entity in this market.
- 2The top 351 suppliers collectively account for 53.4% of all tracked Ketorolac exports, with a combined trade value of $115.9M.
- 3United States is the largest destination market, absorbing 63.1% of India's Ketorolac exports ($73.2M). Russia (23.4%) and Canada (2.7%) follow.
- 4With 3.0K total shipments averaging $39.1K each, the Ketorolac export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include EVERSANA LIFE SCIENCE SERVICES LLC, JUNO PHARMACEUTICALS CORP, EVERSANA LIFE SCIENCE SERVICES LLC, EVERSANA EVERSANA — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 124 countries
Network value: $115.9M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ketorolac — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Ketorolac.
- 2.Flow Mapping: 351 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,961 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 124 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,961 Verified Shipments
351 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists